• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Elray Resources Announces Strategic Sale of Crypto iGaming Technology

    10/25/24 9:00:00 AM ET
    $ATNF
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ATNF alert in real time by email

    LAS VEGAS, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Elray Resources Inc. (OTCPK:ELRA) is pleased to announce a significant milestone in the company's growth strategy.

    Elray has completed the sale of proprietary technology to 180 Life Sciences Corp. (NASDAQ:ATNF), a NASDAQ-listed company in exchange for preferred stock convertible into a 40% stake in ATNF and warrants to purchase 3 million shares of ATNF common stock, the conversion/exercise of which is subject to stockholder approval. The technology stack contained within Elray's technology package will assist ATNF in launching an iGaming Blockchain casino.

    "This strategic sale and potential future partnership are expected to enhance Elray's financial position, support future innovation and open new opportunities and revenue streams for the company," said Vincent Cai, CTO of Elray Resources. "This will not only strengthen our balance sheet considerably, but also will enable ATNF and Elray to collaborate with leading players in the market. We look forward to announcing relationships with new operators, which will deliver even greater value to shareholders and propel our business forward."

    About Elray Resources

    Elray Resources Inc., based in Las Vegas, Nevada, provides turnkey solutions and consulting services for various online e-commerce companies. Elray is a developer, licensor and operator of Crypto iGaming Solutions. The Company has developed highly modular, configurable and scalable Crypto iGaming platforms which offer the tools and features required to operate and maintain an iGaming Blockchain operation. Elray's Crypto iGaming solution has a gaming portfolio provided by over 30 of the world's leading gaming content publishers, presenting players with the latest crypto games, slots, tables, live, sportsbook and competition products.

    Forward-Looking Statements

    Certain statements made in this press release contain forward-looking information within the meaning of applicable securities laws, including within the meaning of the Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). These forward-looking statements represent the Company's current expectations or beliefs concerning future events and can generally be identified using statements that include words such as "estimate," "expects," "project," "believe," "anticipate," "intend," "plan," "foresee," "forecast," "likely," "will," "target" or similar words or phrases. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of the Company's control which could cause actual results to differ materially from the results expressed or implied in the forward-looking statements, including, but not limited to, the impact of the COVID-19 pandemic on the Company; the need for additional financing, the terms of such financing and the availability of such financing; the ability of the Company and/or its subsidiaries to obtain additional gaming licenses; the ability of the Company to manage growth; the Company's ability to complete acquisitions and the available funding for such acquisitions; disruptions caused by acquisitions; dilution caused by fund raising, the conversion of outstanding preferred stock and/or acquisitions; the Company's ability to maintain the listing of its common stock on the Nasdaq Capital Market; the Company's expectations for future growth, revenues, and profitability; the Company's expectations regarding future plans and timing thereof; the Company's reliance on its management; the fact that the Company's chief executive officer has voting control over the Company; related party relationships; the potential effect of economic downturns, recessions, increases in interest rates and inflation, and market conditions, decreases in discretionary spending and therefore demand for our products, and increases in the cost of capital, related thereto, among other affects thereof, on the Company's operations and prospects; the Company's ability to protect proprietary information; the ability of the Company to compete in its market; the Company's lack of effective internal controls; dilution caused by efforts to obtain additional financing; the effect of current and future regulation, the Company's ability to comply with regulations and potential penalties in the event it fails to comply with such regulations and changes in the enforcement and interpretation of existing laws and regulations and the adoption of new laws and regulations that may unfavorably impact our business; the risks associated with gaming fraud, user cheating and cyber-attacks; risks associated with systems failures and failures of technology and infrastructure on which the Company's programs rely; foreign exchange and currency risks; the outcome of contingencies, including legal proceedings in the normal course of business; the ability to compete against existing and new competitors; the ability to manage expenses associated with sales and marketing and necessary general and administrative and technology investments; and general consumer sentiment and economic conditions that may affect levels of discretionary customer purchases of the Company's products, including potential recessions and global economic slowdowns. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this release are reasonable, we provide no assurance that these plans, intentions or expectations will be achieved. Consequently, you should not consider any such list to be a complete set of all potential risks and uncertainties. More information on potential factors that could affect the Company's financial results is included from time to time in the "Special Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's periodic and current filings with the OTC Markets. All subsequent written and oral forward-looking statements attributable to the Company or any person acting on behalf of the Company are expressly qualified in their entirety by the cautionary statements referenced above. Other unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

    Connect with us:

    Twitter – https://twitter.com/ELRA_Official

    Instagram – https://www.instagram.com/elray.gaming/

    Elray Resources Inc.

    Contact: Vincent Cai

    Email: [email protected]



    Primary Logo

    Get the next $ATNF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • What significant transaction did Elray Resources Inc. recently complete?

      Elray Resources Inc. has completed a significant sale of proprietary technology to 180 Life Sciences Corp. for preferred stock and warrants, enhancing Elray's financial position and collaboration capabilities.

    • What equity stake and additional options has Elray gained from the sale of its technology?

      The deal enables Elray to gain a 40% stake in 180 Life Sciences Corp. and warrants to purchase an additional 3 million shares, pending stockholder approval.

    • How will the technology sold by Elray be utilized by 180 Life Sciences Corp.?

      The technology sold will assist ATNF in launching an iGaming Blockchain casino, expanding both companies' opportunity for innovation and new revenue streams.

    • What are the expected benefits of the sale according to Elray's CTO, Vincent Cai?

      Vincent Cai, CTO of Elray Resources, indicated that the sale will considerably strengthen the company's balance sheet and support future partnerships and innovation.

    • What are some of the risks associated with the forward-looking statements made by Elray Resources in their announcement?

      Forward-looking statements provided in the press release caution investors about potential risks such as market conditions, regulatory changes, and operational uncertainties affecting future results.

    Recent Analyst Ratings for
    $ATNF

    DatePrice TargetRatingAnalyst
    9/15/2021$11.00Buy
    Maxim Group
    More analyst ratings

    $ATNF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • 180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

      PALO ALTO, CA / ACCESSWIRE / December 27, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international entertainment and iGaming sector, today announced that it has entered into a securities purchase agreement with several institutional investors to sell 1,200,000 shares of common stock in a registered direct offering priced at market under Nasdaq rules. In a concurrent private placement, the Company also agreed to issue unregistered warrants to purchase up to an aggregate of 1,200,000 shares of common stock. The combined effective offering price for each share of common stock and accompanying wa

      12/27/24 9:00:00 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • 180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

      PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit committee consisting of three independent directors. This development follows the recent appointment of Mr. Stephen Shoemaker as an independent director of the Company and as a member of the Company's audit committee. With this appointment, 180 is now in full compliance with all Nasdaq continued listing requirements and has remedied all previously announced deficiencies.Mr. Blair Jordan, Interim CEO of the Company, stated, "This brings 180 into f

      12/12/24 8:00:00 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • 180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

      PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international entertainment and iGaming sector, today announced the appointment of Stephen Shoemaker to its Board of Directors, effective December 3, 2024.Mr. Shoemaker brings to 180 a wealth of experience as a seasoned senior executive and board member with a diverse background spanning finance, operations management, capital raising, and strategic planning. With over $2 billion in capital raised during his tenure in both CEO and CFO roles across four companies, Mr. Shoemaker has consistently demonstrated his

      12/4/24 8:00:00 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ATNF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Woody James N. bought $4,700 worth of shares (25,000 units at $0.19), increasing direct ownership by 60% to 66,888 units (SEC Form 4)

      4 - 180 Life Sciences Corp. (0001690080) (Issuer)

      12/18/23 4:15:16 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ATNF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by 180 Life Sciences Corp.

      SC 13G/A - 180 Life Sciences Corp. (0001690080) (Subject)

      11/14/24 3:53:30 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by 180 Life Sciences Corp.

      SC 13G - 180 Life Sciences Corp. (0001690080) (Subject)

      10/18/24 5:00:02 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by 180 Life Sciences Corp.

      SC 13G - 180 Life Sciences Corp. (0001690080) (Subject)

      2/14/24 3:27:19 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ATNF
    Financials

    Live finance-specific insights

    See more
    • 180 Life Sciences Corp. - Corporate Updates

      Announcing Acquisition of Advanced Gaming Technology Platform, Positive Progress on Legacy CBD Formulation, and Strengthened Balance SheetPALO ALTO, CA / ACCESSWIRE / October 3, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180") is pleased to provide a corporate update covering several key initiatives.CORPORATE UPDATE HIGHLIGHTS:Company shifts focus and enters global iGaming market - completes a significant technology acquisitionExpected Compliance with Nasdaq Listing Rule 5550(b)(1) - Company expects to meet Nasdaq continued listing requirement which requires maintenance of stockholders' equity of at least $2.5 millionPositive Study Results on CBD Pill Forms - 180 achieve

      10/3/24 8:30:00 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ATNF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Jordan Blair acquired 1,318,000 shares (SEC Form 4)

      4 - 180 Life Sciences Corp. (0001690080) (Issuer)

      4/30/25 5:57:06 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Large owner Elray Resources, Inc. converted options into 1,318,000 shares (SEC Form 4)

      4 - 180 Life Sciences Corp. (0001690080) (Issuer)

      4/11/25 6:05:04 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Jordan Blair acquired 200,000 shares (SEC Form 4)

      4 - 180 Life Sciences Corp. (0001690080) (Issuer)

      4/2/25 4:59:04 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ATNF
    SEC Filings

    See more
    • SEC Form S-3 filed by 180 Life Sciences Corp.

      S-3 - 180 Life Sciences Corp. (0001690080) (Filer)

      5/9/25 4:15:31 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form 10-K/A filed by 180 Life Sciences Corp.

      10-K/A - 180 Life Sciences Corp. (0001690080) (Filer)

      5/8/25 4:20:24 PM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • 180 Life Sciences Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - 180 Life Sciences Corp. (0001690080) (Filer)

      5/1/25 9:18:16 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ATNF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Maxim Group initiated coverage on 180 Life Sciences Corp. with a new price target

      Maxim Group initiated coverage of 180 Life Sciences Corp. with a rating of Buy and set a new price target of $11.00

      9/15/21 7:48:59 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ATNF
    Leadership Updates

    Live Leadership Updates

    See more
    • 180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

      PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit committee consisting of three independent directors. This development follows the recent appointment of Mr. Stephen Shoemaker as an independent director of the Company and as a member of the Company's audit committee. With this appointment, 180 is now in full compliance with all Nasdaq continued listing requirements and has remedied all previously announced deficiencies.Mr. Blair Jordan, Interim CEO of the Company, stated, "This brings 180 into f

      12/12/24 8:00:00 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • 180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

      PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international entertainment and iGaming sector, today announced the appointment of Stephen Shoemaker to its Board of Directors, effective December 3, 2024.Mr. Shoemaker brings to 180 a wealth of experience as a seasoned senior executive and board member with a diverse background spanning finance, operations management, capital raising, and strategic planning. With over $2 billion in capital raised during his tenure in both CEO and CFO roles across four companies, Mr. Shoemaker has consistently demonstrated his

      12/4/24 8:00:00 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • 180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

      PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective immediately. Mr. Goodman brings over a decade of expertise in the software-as-a-service (SaaS) and iGaming industries, along with more than seven years of experience in executive leadership roles. Mr. Goodman's distinguished career includes contributions to several high-growth companies, successful IPOs, and extensive work in the Asia Pacific and Japan markets.Currently, Mr. Goodman serves as Sales Director for Asia Pacific and Japan at Docker, Inc., a position he has held since January 2024. Doc

      10/29/24 8:00:00 AM ET
      $ATNF
      Biotechnology: Pharmaceutical Preparations
      Health Care